Learn more

CEDARS SINAI MEDICAL CENTER

Overview
  • Total Patents
    1,985
  • GoodIP Patent Rank
    1,996
  • Filing trend
    ⇩ 9.0%
About

CEDARS SINAI MEDICAL CENTER has a total of 1,985 patent applications. It decreased the IP activity by 9.0%. Its first patent ever was published in 1982. It filed its patents most often in United States, WIPO (World Intellectual Property Organization) and EPO (European Patent Office). Its main competitors in its focus markets pharmaceuticals, biotechnology and medical technology are CEDARS-SINAI MEDICAL CENTER, TIANJIN MEDICAL UNIV GENERAL HOSPITAL and HOSPITAL FOR SICK CHILDREN.

Patent filings per year

Chart showing CEDARS SINAI MEDICAL CENTERs patent filings per year from 1900 to 2020

Top inventors

# Name Total Patents
#1 Targan Stephan R 162
#2 Pimentel Mark 132
#3 Rotter Jerome I 114
#4 Black Keith L 86
#5 Taylor Kent D 82
#6 Lin Henry C 63
#7 Melmed Shlomo 62
#8 Yu John S 60
#9 Svendsen Clive 55
#10 Yang Huiying 54

Latest patents

Publication Filing date Title
WO2021081237A1 Mesh chopping of neural progenitor cell aggregates
WO2021081229A1 Cortical neural progenitor cells from ipscs
WO2021076399A1 Internal ultraviolet therapy
WO2021062272A2 Analysis methods for multiplex tissue imaging including imaging mass cytometry data
WO2021050765A1 Systems and methods of deep learning for large-scale dynamic magnetic resonance image reconstruction
WO2021046361A1 Use of calcineurin inhibitor free ctla4-ig + anti-il6/il6r for long term immunosuppression in solid organ transplant recipients
WO2021050214A1 Apparatus and method for forming a custom cement-on-cement articulating hip spacer
US2021106844A1 Internal ultraviolet therapy
WO2021026522A2 Method of generating activated t cells for cancer therapy
WO2021026507A1 Methods of improving organ function
WO2021011559A1 Oxygenating bite block
US2020408766A1 Palmitoyl Protein Biomarkers in Purified Extracellular Vesicles for Early Identification of Clinically Significant Prostate Cancer
WO2020257205A1 SYSTEMS AND METHODS FOR IN VIVO DUAL RECOMBINASE-MEDIATED CASSETTE EXCHANGE (dRMCE) AND DISEASE MODELS THEREOF
US2020284804A1 Methods for Detecting Post-Infectious Irritable Bowel Syndrome
WO2020227489A1 Therapeutically active cells and exosomes
US2020342958A1 Methods and systems for assessing inflammatory disease with deep learning
US2020318162A1 Gut bacteria in patients with inflammatory bowel disease and methods therewith in detecting ileal fibrosis
WO2020191076A1 Compositions and methods to treat gastrointestinal diseases and disorders
US2020206304A1 Methods and compositions for efficient delivery through multiple bio barriers
WO2020185672A1 Anti-cd38 agents for desensitization and treatment of antibody-mediated rejection of organ transplants